TARGET TEMPERATURE MANAGEMENT IN 2016 Target temperature management (TTM) is well-known to reduce secondary cell damage after cardiac arrest in patients with presumed cerebral hypoxia. The treatment of this reperfusion syndrome, especially in terms of temperature management, is not fully understood. Several clinical randomized controlled trials and other studies have shown TTM’s effectiveness in improving […]
TARGET TEMPERATURE MANAGEMENT IN 2016 Target temperature management (TTM) is well-known to reduce secondary cell damage after cardiac arrest in patients with presumed cerebral hypoxia. The treatment of this reperfusion syndrome, especially in terms of temperature management, is not fully understood. Several clinical randomized controlled trials and other studies have shown TTM’s effectiveness in improving […]
THE PAST In animal trials clinical outcome and histopathological damage of the brain tissue due to hypoxia after cardiac arrest was found to be reduced by mild therapeutic hypothermia.(,) The clinical milestone trials in 2002 also have found mild therapeutic hypothermia at 32°-34 °C for 12-24 hours to be neuroprotective in treatment of the post-cardiac […]
THE PAST In animal trials clinical outcome and histopathological damage of the brain tissue due to hypoxia after cardiac arrest was found to be reduced by mild therapeutic hypothermia.(,) The clinical milestone trials in 2002 also have found mild therapeutic hypothermia at 32°-34 °C for 12-24 hours to be neuroprotective in treatment of the post-cardiac […]